Referred to the House Committee on the Budget.
The bill codifies a new Panel of Health Advisors within the Congressional Budget Office (CBO). It requires the 15-member panel to provide technical advice on CBO health studies, cost estimates, models, and publications, meet at least annually, and issue a public annual report.
Liberty vs risk: liberals emphasize analytic benefits; conservatives fear bureaucracy expansion.
Relative to its intended legislative type, this bill largely accomplishes the core statutory work required to create and define an advisory Panel of Health Advisors within the CBO: clear duties and priority areas, membership composition and terms, reporting and publication requirements, and some conflict/confidentiality authorities.
The bill codifies a new Panel of Health Advisors within the Congressional Budget Office (CBO).
It requires the 15-member panel to provide technical advice on CBO health studies, cost estimates, models, and publications, meet at least annually, and issue a public annual report.
Members are appointed by budget committee leaders and the CBO Director, serve as special Government employees for three-year staggered terms (limit two terms), and the Director may set disclosure and confidentiality rules.
Modest likelihood: technical, low‑cost measure with bipartisan elements, but some stakeholding and Senate procedures introduce friction.
Relative to its intended legislative type, this bill largely accomplishes the core statutory work required to create and define an advisory Panel of Health Advisors within the CBO: clear duties and priority areas, membership composition and terms, reporting and publication requirements, and some conflict/confidentiality authorities. Key operational and integration gaps remain unaddressed in the text.
Liberty vs risk: liberals emphasize analytic benefits; conservatives fear bureaucracy expansion.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberty vs risk: liberals emphasize analytic benefits; conservatives fear bureaucracy expansion.
Generally supportive as a way to strengthen CBO’s technical capacity on health and improve evidence-based budget analysis.
Values the public report and Director’s obligation to describe use of recommendations.
Would be concerned about industry influence and confidentiality provisions unless strong disclosures exist.
Cautiously favorable as a technocratic improvement to CBO capacity, since the Director must report on recommendation use.
Sees benefits in bipartisan appointments but worries about politicization and added bureaucracy or hidden costs.
Skeptical about creating another advisory body within CBO; concerned it expands federal bureaucracy and could be used to push policy preferences.
Some value in better cost estimates, but wary of confidentiality and added costs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest likelihood: technical, low‑cost measure with bipartisan elements, but some stakeholding and Senate procedures introduce friction.
The bill has not accumulated any surfaced votes yet.
Liberty vs risk: liberals emphasize analytic benefits; conservatives fear bureaucracy expansion.
Modest likelihood: technical, low‑cost measure with bipartisan elements, but some stakeholding and Senate procedures introduce friction.
Relative to its intended legislative type, this bill largely accomplishes the core statutory work required to create and define an advisory Panel of Health Advisors within the CBO: clear duties and priority areas, membe…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.